Bioceres SA DRC (BIOXm)

Currency in ARS
397.25
-3.25(-0.81%)
Closed·
BIOXm is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
355.25399.50
52 wk Range
343.002,627.50
Key Statistics
Bid/Ask
395.00 / 396.00
Prev. Close
400.5
Open
390.25
Day's Range
355.25-399.5
52 wk Range
343-2,627.5
Volume
107.33K
Average Volume (3m)
158.77K
1-Year Change
-84.7651%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOXm Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Bioceres SA DRC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Earnings

Latest Release
Sep 14, 2026
EPS / Forecast
-0.39 / --
Revenue / Forecast
57M / --
EPS Revisions
Last 90 days

BIOXm Income Statement

Compare BIOXm to Peers and Sector

Metrics to compare
BIOXm
Peers
Sector
Relationship
P/E Ratio
−0.2x8.2x3.9x
PEG Ratio
0.000.000.00
Price/Book
0.6x1.6x1.6x
Price / LTM Sales
0.1x1.2x1.1x
Upside (Analyst Target)
-37.9%50.4%
Fair Value Upside
Unlock1.8%6.3%Unlock

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions in Argentina, Brazil, the rest of Latin America, and internationally. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The company offers biological crop nutrition products comprising seed inoculants under the Rizoliq and UHC brands, biofertilizers, and biostimulants; biocontrol products, including bionematicides, biofungicides, and bioinsecticides; crop nutrition and crop protection products, such as micro-beaded fertilizers and adjuvants; and seed germplasms, GMO and non-GMO traits, and ready-to-use seed treatment pack solutions for healthier and higher yielding crops. It also provides fungicide products under the Rizoderma brand; Rizofos for foliar applications; therapies, herbicides, and baits; and bio-inductors, crop health products, and biological and micro granulated fertilizers. In addition, the company licenses its HB4 seed trait for drought tolerance in wheat and soybean seeds. It sells its products to blue-chip companies and industry leaders, large distributors, co-ops, dealers, large farmers, and individual growers through distributors and dealers. The company was founded in 2001 and is headquartered in Rosario, Argentina.

Industry
Chemicals
Employees
562
Market
Argentina

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.30M2.03%515.41M
Other Institutional Investors
24.54M38.45%9.75B
Public Companies & Retail Investors
37.98M59.51%15.09B
Total
63.82M100.00%25.35B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Ospraie Management, LLC9.77%6,233,5902,476,294
Solel Partners LP7.18%4,579,3641,819,152

FAQ

What Is the Bioceres DRC (BIOXm) Stock Price Today?

The Bioceres DRC stock price today is 397.25 ARS.

What Stock Exchange Does Bioceres DRC Trade On?

Bioceres DRC is listed and trades on the Buenos Aires Stock Exchange.

What Is the Stock Symbol for Bioceres DRC?

The stock symbol for Bioceres DRC is "BIOXm."

What Is the Bioceres DRC Market Cap?

As of today, Bioceres DRC market cap is 21.87B ARS.

What Is Bioceres DRC's Earnings Per Share (TTM)?

The Bioceres DRC EPS (TTM) is -1,960.

From a Technical Analysis Perspective, Is BIOXm a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bioceres DRC Stock Split?

Bioceres DRC has split 1 times.

How Many Employees Does Bioceres DRC Have?

Bioceres DRC has 562 employees.

What is the current trading status of Bioceres DRC (BIOXm)?

As of Nov 14, 2026, Bioceres DRC (BIOXm) is trading at a price of 397.25 ARS, with a previous close of 400.50 ARS. The stock has fluctuated within a day range of 355.25 ARS to 399.50 ARS, while its 52-week range spans from 343.00 ARS to 2,627.50 ARS.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.